Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Stahley MR"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Musunuru K; Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Chadwick AC; Verve Therapeutics, Cambridge, MA, USA., Mizoguchi T; Verve Therapeutics, Cambridge, MA, USA., Garcia SP; Verve Therapeutics, Cambridge, MA, USA., DeNizio JE; Verve Therapeutics, Cambridge, MA, USA., Reiss CW; Verve Therapeutics, Cambridge, MA, USA., Wang K; Verve Therapeutics, Cambridge, MA, USA., Iyer S; Verve Therapeutics, Cambridge, MA, USA., Dutta C; Verve Therapeutics, Cambridge, MA, USA., Clendaniel V; Verve Therapeutics, Cambridge, MA, USA., Amaonye M; Verve Therapeutics, Cambridge, MA, USA., Beach A; Verve Therapeutics, Cambridge, MA, USA., Berth K; Verve Therapeutics, Cambridge, MA, USA., Biswas S; Verve Therapeutics, Cambridge, MA, USA., Braun MC; Verve Therapeutics, Cambridge, MA, USA., Chen HM; Verve Therapeutics, Cambridge, MA, USA., Colace TV; Verve Therapeutics, Cambridge, MA, USA., Ganey JD; Verve Therapeutics, Cambridge, MA, USA., Gangopadhyay SA; Verve Therapeutics, Cambridge, MA, USA., Garrity R; Verve Therapeutics, Cambridge, MA, USA., Kasiewicz LN; Verve Therapeutics, Cambridge, MA, USA., Lavoie J; Verve Therapeutics, Cambridge, MA, USA., Madsen JA; Verve Therapeutics, Cambridge, MA, USA., Matsumoto Y; Verve Therapeutics, Cambridge, MA, USA., Mazzola AM; Verve Therapeutics, Cambridge, MA, USA., Nasrullah YS; Verve Therapeutics, Cambridge, MA, USA., Nneji J; Verve Therapeutics, Cambridge, MA, USA., Ren H; Verve Therapeutics, Cambridge, MA, USA., Sanjeev A; Verve Therapeutics, Cambridge, MA, USA., Shay M; Verve Therapeutics, Cambridge, MA, USA., Stahley MR; Verve Therapeutics, Cambridge, MA, USA., Fan SHY; Acuitas Therapeutics, Vancouver, British Columbia, Canada., Tam YK; Acuitas Therapeutics, Vancouver, British Columbia, Canada., Gaudelli NM; Beam Therapeutics, Cambridge, MA, USA., Ciaramella G; Beam Therapeutics, Cambridge, MA, USA., Stolz LE; Verve Therapeutics, Cambridge, MA, USA., Malyala P; Verve Therapeutics, Cambridge, MA, USA., Cheng CJ; Verve Therapeutics, Cambridge, MA, USA., Rajeev KG; Verve Therapeutics, Cambridge, MA, USA., Rohde E; Verve Therapeutics, Cambridge, MA, USA., Bellinger AM; Verve Therapeutics, Cambridge, MA, USA., Kathiresan S; Verve Therapeutics, Cambridge, MA, USA. skathiresan@vervetx.com.
Publikováno v:
Nature [Nature] 2021 May; Vol. 593 (7859), pp. 429-434. Date of Electronic Publication: 2021 May 19.
Autor:
Farelli JD; 1 Discovery Research, Alexion Pharmaceuticals, Inc. , Cambridge, Massachusetts., Asrani KH; 1 Discovery Research, Alexion Pharmaceuticals, Inc. , Cambridge, Massachusetts., Isaacs C; 1 Discovery Research, Alexion Pharmaceuticals, Inc. , Cambridge, Massachusetts., deBear JS; 2 Nucleic Acid Technology, Alexion Pharmaceuticals, Inc. , New Haven, Connecticut., Stahley MR; 2 Nucleic Acid Technology, Alexion Pharmaceuticals, Inc. , New Haven, Connecticut., Shah A; 3 Preclinical Pharmacology, Alexion Pharmaceuticals, Inc. , New Haven, Connecticut., Lasaro MA; 3 Preclinical Pharmacology, Alexion Pharmaceuticals, Inc. , New Haven, Connecticut., Cheng CJ; 2 Nucleic Acid Technology, Alexion Pharmaceuticals, Inc. , New Haven, Connecticut., Subramanian RR; 1 Discovery Research, Alexion Pharmaceuticals, Inc. , Cambridge, Massachusetts.
Publikováno v:
Nucleic acid therapeutics [Nucleic Acid Ther] 2018 Apr; Vol. 28 (2), pp. 74-85. Date of Electronic Publication: 2018 Feb 13.
Autor:
Asrani KH; a Alexion Pharmaceuticals Inc. , Cambridge MA., Farelli JD; a Alexion Pharmaceuticals Inc. , Cambridge MA., Stahley MR; b Alexion Pharmaceuticals Inc. , New Haven CT., Miller RL; b Alexion Pharmaceuticals Inc. , New Haven CT., Cheng CJ; b Alexion Pharmaceuticals Inc. , New Haven CT., Subramanian RR; a Alexion Pharmaceuticals Inc. , Cambridge MA., Brown JM; a Alexion Pharmaceuticals Inc. , Cambridge MA.
Publikováno v:
RNA biology [RNA Biol] 2018; Vol. 15 (6), pp. 756-762. Date of Electronic Publication: 2018 Mar 26.
Autor:
Ye Y; Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, WBSB 314, 725 North Wolfe Street, Baltimore, MD 21205, USA., Stahley MR, Xu J, Friedman JI, Sun Y, McKnight JN, Gray JJ, Bowman GD, Stivers JT
Publikováno v:
Biochemistry [Biochemistry] 2012 Jul 31; Vol. 51 (30), pp. 6028-38. Date of Electronic Publication: 2012 Jul 23.
Autor:
Feng Y; Department of Chemistry, Georgia State University, Atlanta, Georgia 30302, United States., Xie N, Jin M, Stahley MR, Stivers JT, Zheng YG
Publikováno v:
Biochemistry [Biochemistry] 2011 Aug 16; Vol. 50 (32), pp. 7033-44. Date of Electronic Publication: 2011 Jul 21.
Autor:
Karp DA; Department of Biophysics, Johns Hopkins University, 3400 North Charles Street, Baltimore, Maryland 21218, USA., Stahley MR, García-Moreno B
Publikováno v:
Biochemistry [Biochemistry] 2010 May 18; Vol. 49 (19), pp. 4138-46.